Castle Biosciences Inc is a pioneer in the field of molecular diagnostics, specialising in the design, development, and commercialisation of innovative diagnostic tests for undiagnosed diseases. Its aim is to enhance and personalise patient care on a global scale.
As part of the healthcare sector, particularly the biotechnology and medical research industries, Castle Biosciences aims to shape the future of therapeutic strategies. Its portfolio includes diagnostic and prognostic tests for skin and eye cancers, Barrett's oesophagus and mental health conditions.
Stay up to date on the share price of CSTL by adding it to your eToro watchlist.